Global Small Molecule Drug CDMO Services Market Research Report 2025(Status and Outlook)
Report Overview
Small molecule drug CDMO services refer to outsourcing services for the development and production of small molecule drugs. CDMO (Contract Development and Manufacturing Organization) is a third-party organization that specializes in drug development and production. It provides customized services to pharmaceutical companies, covering the entire process from the drug development stage to the commercial production stage. CDMO services for small molecule drugs usually include drug development support, clinical trial support, production process optimization, commercial production, quality control and compliance support. By choosing CDMO services, pharmaceutical companies can focus on their core business and outsource drug R&D and production to professional organizations, thereby improving efficiency, reducing risks, and accelerating the launch of new drugs.
This report provides a deep insight into the global Small Molecule Drug CDMO Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Small Molecule Drug CDMO Services Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Small Molecule Drug CDMO Services market in any manner.
Global Small Molecule Drug CDMO Services Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Thermo Fisher Scientific
Zhejiang Jiuzhou Pharmaceutical
Porton Fine Chemicals
Lonza Group
JOINN Biologics
Zhejiang Langhua Pharmaceutical
Kingchem (Liaoning) Life Science
Market Segmentation (by Type)
Preparation
Chemical API
Market Segmentation (by Application)
Clinical Treatment
Medical Research
Commercial Production
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Small Molecule Drug CDMO Services Market
- Overview of the regional outlook of the Small Molecule Drug CDMO Services Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Small Molecule Drug CDMO Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Small Molecule Drug CDMO Services
1.2 Key Market Segments
1.2.1 Small Molecule Drug CDMO Services Segment by Type
1.2.2 Small Molecule Drug CDMO Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SMALL MOLECULE DRUG CDMO SERVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Small Molecule Drug CDMO Services Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Small Molecule Drug CDMO Services Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SMALL MOLECULE DRUG CDMO SERVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Small Molecule Drug CDMO Services Product Life Cycle
3.3 Global Small Molecule Drug CDMO Services Sales by Manufacturers (2020-2025)
3.4 Global Small Molecule Drug CDMO Services Revenue Market Share by Manufacturers (2020-2025)
3.5 Small Molecule Drug CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Small Molecule Drug CDMO Services Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Small Molecule Drug CDMO Services Manufacturing Sites, Area Served, Product Type
3.8 Small Molecule Drug CDMO Services Market Competitive Situation and Trends
3.8.1 Small Molecule Drug CDMO Services Market Concentration Rate
3.8.2 Global 5 and 10 Largest Small Molecule Drug CDMO Services Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SMALL MOLECULE DRUG CDMO SERVICES INDUSTRY CHAIN ANALYSIS
4.1 Small Molecule Drug CDMO Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SMALL MOLECULE DRUG CDMO SERVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Small Molecule Drug CDMO Services Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Small Molecule Drug CDMO Services Market
5.7 ESG Ratings of Leading Companies
6 SMALL MOLECULE DRUG CDMO SERVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Small Molecule Drug CDMO Services Sales Market Share by Type (2020-2025)
6.3 Global Small Molecule Drug CDMO Services Market Size Market Share by Type (2020-2025)
6.4 Global Small Molecule Drug CDMO Services Price by Type (2020-2025)
7 SMALL MOLECULE DRUG CDMO SERVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Small Molecule Drug CDMO Services Market Sales by Application (2020-2025)
7.3 Global Small Molecule Drug CDMO Services Market Size (M USD) by Application (2020-2025)
7.4 Global Small Molecule Drug CDMO Services Sales Growth Rate by Application (2020-2025)
8 SMALL MOLECULE DRUG CDMO SERVICES MARKET SALES BY REGION
8.1 Global Small Molecule Drug CDMO Services Sales by Region
8.1.1 Global Small Molecule Drug CDMO Services Sales by Region
8.1.2 Global Small Molecule Drug CDMO Services Sales Market Share by Region
8.2 Global Small Molecule Drug CDMO Services Market Size by Region
8.2.1 Global Small Molecule Drug CDMO Services Market Size by Region
8.2.2 Global Small Molecule Drug CDMO Services Market Size Market Share by Region
8.3 North America
8.3.1 North America Small Molecule Drug CDMO Services Sales by Country
8.3.2 North America Small Molecule Drug CDMO Services Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Small Molecule Drug CDMO Services Sales by Country
8.4.2 Europe Small Molecule Drug CDMO Services Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Small Molecule Drug CDMO Services Sales by Region
8.5.2 Asia Pacific Small Molecule Drug CDMO Services Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Small Molecule Drug CDMO Services Sales by Country
8.6.2 South America Small Molecule Drug CDMO Services Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Small Molecule Drug CDMO Services Sales by Region
8.7.2 Middle East and Africa Small Molecule Drug CDMO Services Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SMALL MOLECULE DRUG CDMO SERVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Small Molecule Drug CDMO Services by Region(2020-2025)
9.2 Global Small Molecule Drug CDMO Services Revenue Market Share by Region (2020-2025)
9.3 Global Small Molecule Drug CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Small Molecule Drug CDMO Services Production
9.4.1 North America Small Molecule Drug CDMO Services Production Growth Rate (2020-2025)
9.4.2 North America Small Molecule Drug CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Small Molecule Drug CDMO Services Production
9.5.1 Europe Small Molecule Drug CDMO Services Production Growth Rate (2020-2025)
9.5.2 Europe Small Molecule Drug CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Small Molecule Drug CDMO Services Production (2020-2025)
9.6.1 Japan Small Molecule Drug CDMO Services Production Growth Rate (2020-2025)
9.6.2 Japan Small Molecule Drug CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Small Molecule Drug CDMO Services Production (2020-2025)
9.7.1 China Small Molecule Drug CDMO Services Production Growth Rate (2020-2025)
9.7.2 China Small Molecule Drug CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Gliead
10.1.1 Gliead Basic Information
10.1.2 Gliead Small Molecule Drug CDMO Services Product Overview
10.1.3 Gliead Small Molecule Drug CDMO Services Product Market Performance
10.1.4 Gliead Business Overview
10.1.5 Gliead SWOT Analysis
10.1.6 Gliead Recent Developments
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Basic Information
10.2.2 Boehringer Ingelheim Small Molecule Drug CDMO Services Product Overview
10.2.3 Boehringer Ingelheim Small Molecule Drug CDMO Services Product Market Performance
10.2.4 Boehringer Ingelheim Business Overview
10.2.5 Boehringer Ingelheim SWOT Analysis
10.2.6 Boehringer Ingelheim Recent Developments
10.3 Vertex
10.3.1 Vertex Basic Information
10.3.2 Vertex Small Molecule Drug CDMO Services Product Overview
10.3.3 Vertex Small Molecule Drug CDMO Services Product Market Performance
10.3.4 Vertex Business Overview
10.3.5 Vertex SWOT Analysis
10.3.6 Vertex Recent Developments
10.4 Mirati Therapeutics
10.4.1 Mirati Therapeutics Basic Information
10.4.2 Mirati Therapeutics Small Molecule Drug CDMO Services Product Overview
10.4.3 Mirati Therapeutics Small Molecule Drug CDMO Services Product Market Performance
10.4.4 Mirati Therapeutics Business Overview
10.4.5 Mirati Therapeutics Recent Developments
10.5 AMPAC
10.5.1 AMPAC Basic Information
10.5.2 AMPAC Small Molecule Drug CDMO Services Product Overview
10.5.3 AMPAC Small Molecule Drug CDMO Services Product Market Performance
10.5.4 AMPAC Business Overview
10.5.5 AMPAC Recent Developments
10.6 Pfizer
10.6.1 Pfizer Basic Information
10.6.2 Pfizer Small Molecule Drug CDMO Services Product Overview
10.6.3 Pfizer Small Molecule Drug CDMO Services Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Polypeptide
10.7.1 Polypeptide Basic Information
10.7.2 Polypeptide Small Molecule Drug CDMO Services Product Overview
10.7.3 Polypeptide Small Molecule Drug CDMO Services Product Market Performance
10.7.4 Polypeptide Business Overview
10.7.5 Polypeptide Recent Developments
10.8 Bachem
10.8.1 Bachem Basic Information
10.8.2 Bachem Small Molecule Drug CDMO Services Product Overview
10.8.3 Bachem Small Molecule Drug CDMO Services Product Market Performance
10.8.4 Bachem Business Overview
10.8.5 Bachem Recent Developments
10.9 Merck
10.9.1 Merck Basic Information
10.9.2 Merck Small Molecule Drug CDMO Services Product Overview
10.9.3 Merck Small Molecule Drug CDMO Services Product Market Performance
10.9.4 Merck Business Overview
10.9.5 Merck Recent Developments
10.10 Asymchem
10.10.1 Asymchem Basic Information
10.10.2 Asymchem Small Molecule Drug CDMO Services Product Overview
10.10.3 Asymchem Small Molecule Drug CDMO Services Product Market Performance
10.10.4 Asymchem Business Overview
10.10.5 Asymchem Recent Developments
10.11 Thermo Fisher Scientific
10.11.1 Thermo Fisher Scientific Basic Information
10.11.2 Thermo Fisher Scientific Small Molecule Drug CDMO Services Product Overview
10.11.3 Thermo Fisher Scientific Small Molecule Drug CDMO Services Product Market Performance
10.11.4 Thermo Fisher Scientific Business Overview
10.11.5 Thermo Fisher Scientific Recent Developments
10.12 Zhejiang Jiuzhou Pharmaceutical
10.12.1 Zhejiang Jiuzhou Pharmaceutical Basic Information
10.12.2 Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Product Overview
10.12.3 Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Product Market Performance
10.12.4 Zhejiang Jiuzhou Pharmaceutical Business Overview
10.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
10.13 Porton Fine Chemicals
10.13.1 Porton Fine Chemicals Basic Information
10.13.2 Porton Fine Chemicals Small Molecule Drug CDMO Services Product Overview
10.13.3 Porton Fine Chemicals Small Molecule Drug CDMO Services Product Market Performance
10.13.4 Porton Fine Chemicals Business Overview
10.13.5 Porton Fine Chemicals Recent Developments
10.14 Lonza Group
10.14.1 Lonza Group Basic Information
10.14.2 Lonza Group Small Molecule Drug CDMO Services Product Overview
10.14.3 Lonza Group Small Molecule Drug CDMO Services Product Market Performance
10.14.4 Lonza Group Business Overview
10.14.5 Lonza Group Recent Developments
10.15 JOINN Biologics
10.15.1 JOINN Biologics Basic Information
10.15.2 JOINN Biologics Small Molecule Drug CDMO Services Product Overview
10.15.3 JOINN Biologics Small Molecule Drug CDMO Services Product Market Performance
10.15.4 JOINN Biologics Business Overview
10.15.5 JOINN Biologics Recent Developments
10.16 Zhejiang Langhua Pharmaceutical
10.16.1 Zhejiang Langhua Pharmaceutical Basic Information
10.16.2 Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Product Overview
10.16.3 Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Product Market Performance
10.16.4 Zhejiang Langhua Pharmaceutical Business Overview
10.16.5 Zhejiang Langhua Pharmaceutical Recent Developments
10.17 Kingchem (Liaoning) Life Science
10.17.1 Kingchem (Liaoning) Life Science Basic Information
10.17.2 Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Product Overview
10.17.3 Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Product Market Performance
10.17.4 Kingchem (Liaoning) Life Science Business Overview
10.17.5 Kingchem (Liaoning) Life Science Recent Developments
11 SMALL MOLECULE DRUG CDMO SERVICES MARKET FORECAST BY REGION
11.1 Global Small Molecule Drug CDMO Services Market Size Forecast
11.2 Global Small Molecule Drug CDMO Services Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Small Molecule Drug CDMO Services Market Size Forecast by Country
11.2.3 Asia Pacific Small Molecule Drug CDMO Services Market Size Forecast by Region
11.2.4 South America Small Molecule Drug CDMO Services Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Small Molecule Drug CDMO Services by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Small Molecule Drug CDMO Services Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Small Molecule Drug CDMO Services by Type (2026-2033)
12.1.2 Global Small Molecule Drug CDMO Services Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Small Molecule Drug CDMO Services by Type (2026-2033)
12.2 Global Small Molecule Drug CDMO Services Market Forecast by Application (2026-2033)
12.2.1 Global Small Molecule Drug CDMO Services Sales (K MT) Forecast by Application
12.2.2 Global Small Molecule Drug CDMO Services Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Small Molecule Drug CDMO Services Market Size Comparison by Region (M USD)
Table 5. Global Small Molecule Drug CDMO Services Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Small Molecule Drug CDMO Services Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Small Molecule Drug CDMO Services Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Small Molecule Drug CDMO Services Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO Services as of 2024)
Table 10. Global Market Small Molecule Drug CDMO Services Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Small Molecule Drug CDMO Services Manufacturing Sites and Area Served
Table 12. Manufacturers Small Molecule Drug CDMO Services Product Type
Table 13. Global Small Molecule Drug CDMO Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Small Molecule Drug CDMO Services Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Small Molecule Drug CDMO Services Sales by Type (K MT)
Table 25. Global Small Molecule Drug CDMO Services Market Size by Type (M USD)
Table 26. Global Small Molecule Drug CDMO Services Sales (K MT) by Type (2020-2025)
Table 27. Global Small Molecule Drug CDMO Services Sales Market Share by Type (2020-2025)
Table 28. Global Small Molecule Drug CDMO Services Market Size (M USD) by Type (2020-2025)
Table 29. Global Small Molecule Drug CDMO Services Market Size Share by Type (2020-2025)
Table 30. Global Small Molecule Drug CDMO Services Price (USD/MT) by Type (2020-2025)
Table 31. Global Small Molecule Drug CDMO Services Sales (K MT) by Application
Table 32. Global Small Molecule Drug CDMO Services Market Size by Application
Table 33. Global Small Molecule Drug CDMO Services Sales by Application (2020-2025) & (K MT)
Table 34. Global Small Molecule Drug CDMO Services Sales Market Share by Application (2020-2025)
Table 35. Global Small Molecule Drug CDMO Services Market Size by Application (2020-2025) & (M USD)
Table 36. Global Small Molecule Drug CDMO Services Market Share by Application (2020-2025)
Table 37. Global Small Molecule Drug CDMO Services Sales Growth Rate by Application (2020-2025)
Table 38. Global Small Molecule Drug CDMO Services Sales by Region (2020-2025) & (K MT)
Table 39. Global Small Molecule Drug CDMO Services Sales Market Share by Region (2020-2025)
Table 40. Global Small Molecule Drug CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 41. Global Small Molecule Drug CDMO Services Market Size Market Share by Region (2020-2025)
Table 42. North America Small Molecule Drug CDMO Services Sales by Country (2020-2025) & (K MT)
Table 43. North America Small Molecule Drug CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Small Molecule Drug CDMO Services Sales by Country (2020-2025) & (K MT)
Table 45. Europe Small Molecule Drug CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Small Molecule Drug CDMO Services Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Small Molecule Drug CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 48. South America Small Molecule Drug CDMO Services Sales by Country (2020-2025) & (K MT)
Table 49. South America Small Molecule Drug CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Small Molecule Drug CDMO Services Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Small Molecule Drug CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 52. Global Small Molecule Drug CDMO Services Production (K MT) by Region(2020-2025)
Table 53. Global Small Molecule Drug CDMO Services Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Small Molecule Drug CDMO Services Revenue Market Share by Region (2020-2025)
Table 55. Global Small Molecule Drug CDMO Services Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Small Molecule Drug CDMO Services Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Small Molecule Drug CDMO Services Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Small Molecule Drug CDMO Services Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Small Molecule Drug CDMO Services Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Gliead Basic Information
Table 61. Gliead Small Molecule Drug CDMO Services Product Overview
Table 62. Gliead Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Gliead Business Overview
Table 64. Gliead SWOT Analysis
Table 65. Gliead Recent Developments
Table 66. Boehringer Ingelheim Basic Information
Table 67. Boehringer Ingelheim Small Molecule Drug CDMO Services Product Overview
Table 68. Boehringer Ingelheim Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim SWOT Analysis
Table 71. Boehringer Ingelheim Recent Developments
Table 72. Vertex Basic Information
Table 73. Vertex Small Molecule Drug CDMO Services Product Overview
Table 74. Vertex Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Vertex Business Overview
Table 76. Vertex SWOT Analysis
Table 77. Vertex Recent Developments
Table 78. Mirati Therapeutics Basic Information
Table 79. Mirati Therapeutics Small Molecule Drug CDMO Services Product Overview
Table 80. Mirati Therapeutics Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Mirati Therapeutics Business Overview
Table 82. Mirati Therapeutics Recent Developments
Table 83. AMPAC Basic Information
Table 84. AMPAC Small Molecule Drug CDMO Services Product Overview
Table 85. AMPAC Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. AMPAC Business Overview
Table 87. AMPAC Recent Developments
Table 88. Pfizer Basic Information
Table 89. Pfizer Small Molecule Drug CDMO Services Product Overview
Table 90. Pfizer Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Pfizer Business Overview
Table 92. Pfizer Recent Developments
Table 93. Polypeptide Basic Information
Table 94. Polypeptide Small Molecule Drug CDMO Services Product Overview
Table 95. Polypeptide Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Polypeptide Business Overview
Table 97. Polypeptide Recent Developments
Table 98. Bachem Basic Information
Table 99. Bachem Small Molecule Drug CDMO Services Product Overview
Table 100. Bachem Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Bachem Business Overview
Table 102. Bachem Recent Developments
Table 103. Merck Basic Information
Table 104. Merck Small Molecule Drug CDMO Services Product Overview
Table 105. Merck Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Merck Business Overview
Table 107. Merck Recent Developments
Table 108. Asymchem Basic Information
Table 109. Asymchem Small Molecule Drug CDMO Services Product Overview
Table 110. Asymchem Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Asymchem Business Overview
Table 112. Asymchem Recent Developments
Table 113. Thermo Fisher Scientific Basic Information
Table 114. Thermo Fisher Scientific Small Molecule Drug CDMO Services Product Overview
Table 115. Thermo Fisher Scientific Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Thermo Fisher Scientific Business Overview
Table 117. Thermo Fisher Scientific Recent Developments
Table 118. Zhejiang Jiuzhou Pharmaceutical Basic Information
Table 119. Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Product Overview
Table 120. Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 122. Zhejiang Jiuzhou Pharmaceutical Recent Developments
Table 123. Porton Fine Chemicals Basic Information
Table 124. Porton Fine Chemicals Small Molecule Drug CDMO Services Product Overview
Table 125. Porton Fine Chemicals Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 126. Porton Fine Chemicals Business Overview
Table 127. Porton Fine Chemicals Recent Developments
Table 128. Lonza Group Basic Information
Table 129. Lonza Group Small Molecule Drug CDMO Services Product Overview
Table 130. Lonza Group Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 131. Lonza Group Business Overview
Table 132. Lonza Group Recent Developments
Table 133. JOINN Biologics Basic Information
Table 134. JOINN Biologics Small Molecule Drug CDMO Services Product Overview
Table 135. JOINN Biologics Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 136. JOINN Biologics Business Overview
Table 137. JOINN Biologics Recent Developments
Table 138. Zhejiang Langhua Pharmaceutical Basic Information
Table 139. Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Product Overview
Table 140. Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 141. Zhejiang Langhua Pharmaceutical Business Overview
Table 142. Zhejiang Langhua Pharmaceutical Recent Developments
Table 143. Kingchem (Liaoning) Life Science Basic Information
Table 144. Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Product Overview
Table 145. Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 146. Kingchem (Liaoning) Life Science Business Overview
Table 147. Kingchem (Liaoning) Life Science Recent Developments
Table 148. Global Small Molecule Drug CDMO Services Sales Forecast by Region (2026-2033) & (K MT)
Table 149. Global Small Molecule Drug CDMO Services Market Size Forecast by Region (2026-2033) & (M USD)
Table 150. North America Small Molecule Drug CDMO Services Sales Forecast by Country (2026-2033) & (K MT)
Table 151. North America Small Molecule Drug CDMO Services Market Size Forecast by Country (2026-2033) & (M USD)
Table 152. Europe Small Molecule Drug CDMO Services Sales Forecast by Country (2026-2033) & (K MT)
Table 153. Europe Small Molecule Drug CDMO Services Market Size Forecast by Country (2026-2033) & (M USD)
Table 154. Asia Pacific Small Molecule Drug CDMO Services Sales Forecast by Region (2026-2033) & (K MT)
Table 155. Asia Pacific Small Molecule Drug CDMO Services Market Size Forecast by Region (2026-2033) & (M USD)
Table 156. South America Small Molecule Drug CDMO Services Sales Forecast by Country (2026-2033) & (K MT)
Table 157. South America Small Molecule Drug CDMO Services Market Size Forecast by Country (2026-2033) & (M USD)
Table 158. Middle East and Africa Small Molecule Drug CDMO Services Sales Forecast by Country (2026-2033) & (Units)
Table 159. Middle East and Africa Small Molecule Drug CDMO Services Market Size Forecast by Country (2026-2033) & (M USD)
Table 160. Global Small Molecule Drug CDMO Services Sales Forecast by Type (2026-2033) & (K MT)
Table 161. Global Small Molecule Drug CDMO Services Market Size Forecast by Type (2026-2033) & (M USD)
Table 162. Global Small Molecule Drug CDMO Services Price Forecast by Type (2026-2033) & (USD/MT)
Table 163. Global Small Molecule Drug CDMO Services Sales (K MT) Forecast by Application (2026-2033)
Table 164. Global Small Molecule Drug CDMO Services Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Small Molecule Drug CDMO Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Small Molecule Drug CDMO Services Market Size (M USD), 2024-2033
Figure 5. Global Small Molecule Drug CDMO Services Market Size (M USD) (2020-2033)
Figure 6. Global Small Molecule Drug CDMO Services Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Small Molecule Drug CDMO Services Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Small Molecule Drug CDMO Services Product Life Cycle
Figure 13. Small Molecule Drug CDMO Services Sales Share by Manufacturers in 2024
Figure 14. Global Small Molecule Drug CDMO Services Revenue Share by Manufacturers in 2024
Figure 15. Small Molecule Drug CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Small Molecule Drug CDMO Services Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Small Molecule Drug CDMO Services Revenue in 2024
Figure 18. Industry Chain Map of Small Molecule Drug CDMO Services
Figure 19. Global Small Molecule Drug CDMO Services Market PEST Analysis
Figure 20. Global Small Molecule Drug CDMO Services Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Small Molecule Drug CDMO Services Market Share by Type
Figure 27. Sales Market Share of Small Molecule Drug CDMO Services by Type (2020-2025)
Figure 28. Sales Market Share of Small Molecule Drug CDMO Services by Type in 2024
Figure 29. Market Size Share of Small Molecule Drug CDMO Services by Type (2020-2025)
Figure 30. Market Size Share of Small Molecule Drug CDMO Services by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Small Molecule Drug CDMO Services Market Share by Application
Figure 33. Global Small Molecule Drug CDMO Services Sales Market Share by Application (2020-2025)
Figure 34. Global Small Molecule Drug CDMO Services Sales Market Share by Application in 2024
Figure 35. Global Small Molecule Drug CDMO Services Market Share by Application (2020-2025)
Figure 36. Global Small Molecule Drug CDMO Services Market Share by Application in 2024
Figure 37. Global Small Molecule Drug CDMO Services Sales Growth Rate by Application (2020-2025)
Figure 38. Global Small Molecule Drug CDMO Services Sales Market Share by Region (2020-2025)
Figure 39. Global Small Molecule Drug CDMO Services Market Size Market Share by Region (2020-2025)
Figure 40. North America Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Small Molecule Drug CDMO Services Sales Market Share by Country in 2024
Figure 43. North America Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Small Molecule Drug CDMO Services Market Size Market Share by Country in 2024
Figure 45. U.S. Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Small Molecule Drug CDMO Services Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Small Molecule Drug CDMO Services Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Small Molecule Drug CDMO Services Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Small Molecule Drug CDMO Services Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Small Molecule Drug CDMO Services Sales Market Share by Country in 2024
Figure 53. Europe Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Small Molecule Drug CDMO Services Market Size Market Share by Country in 2024
Figure 55. Germany Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Small Molecule Drug CDMO Services Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Small Molecule Drug CDMO Services Sales Market Share by Region in 2024
Figure 67. Asia Pacific Small Molecule Drug CDMO Services Market Size Market Share by Region in 2024
Figure 68. China Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Small Molecule Drug CDMO Services Sales and Growth Rate (K MT)
Figure 79. South America Small Molecule Drug CDMO Services Sales Market Share by Country in 2024
Figure 80. South America Small Molecule Drug CDMO Services Market Size and Growth Rate (M USD)
Figure 81. South America Small Molecule Drug CDMO Services Market Size Market Share by Country in 2024
Figure 82. Brazil Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Small Molecule Drug CDMO Services Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Small Molecule Drug CDMO Services Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Small Molecule Drug CDMO Services Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Small Molecule Drug CDMO Services Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Small Molecule Drug CDMO Services Production Market Share by Region (2020-2025)
Figure 103. North America Small Molecule Drug CDMO Services Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Small Molecule Drug CDMO Services Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Small Molecule Drug CDMO Services Production (K MT) Growth Rate (2020-2025)
Figure 106. China Small Molecule Drug CDMO Services Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Small Molecule Drug CDMO Services Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Small Molecule Drug CDMO Services Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Small Molecule Drug CDMO Services Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Small Molecule Drug CDMO Services Market Share Forecast by Type (2026-2033)
Figure 111. Global Small Molecule Drug CDMO Services Sales Forecast by Application (2026-2033)
Figure 112. Global Small Molecule Drug CDMO Services Market Share Forecast by Application (2026-2033)
1.1 Market Definition and Statistical Scope of Small Molecule Drug CDMO Services
1.2 Key Market Segments
1.2.1 Small Molecule Drug CDMO Services Segment by Type
1.2.2 Small Molecule Drug CDMO Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SMALL MOLECULE DRUG CDMO SERVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Small Molecule Drug CDMO Services Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Small Molecule Drug CDMO Services Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SMALL MOLECULE DRUG CDMO SERVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Small Molecule Drug CDMO Services Product Life Cycle
3.3 Global Small Molecule Drug CDMO Services Sales by Manufacturers (2020-2025)
3.4 Global Small Molecule Drug CDMO Services Revenue Market Share by Manufacturers (2020-2025)
3.5 Small Molecule Drug CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Small Molecule Drug CDMO Services Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Small Molecule Drug CDMO Services Manufacturing Sites, Area Served, Product Type
3.8 Small Molecule Drug CDMO Services Market Competitive Situation and Trends
3.8.1 Small Molecule Drug CDMO Services Market Concentration Rate
3.8.2 Global 5 and 10 Largest Small Molecule Drug CDMO Services Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 SMALL MOLECULE DRUG CDMO SERVICES INDUSTRY CHAIN ANALYSIS
4.1 Small Molecule Drug CDMO Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SMALL MOLECULE DRUG CDMO SERVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Small Molecule Drug CDMO Services Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Small Molecule Drug CDMO Services Market
5.7 ESG Ratings of Leading Companies
6 SMALL MOLECULE DRUG CDMO SERVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Small Molecule Drug CDMO Services Sales Market Share by Type (2020-2025)
6.3 Global Small Molecule Drug CDMO Services Market Size Market Share by Type (2020-2025)
6.4 Global Small Molecule Drug CDMO Services Price by Type (2020-2025)
7 SMALL MOLECULE DRUG CDMO SERVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Small Molecule Drug CDMO Services Market Sales by Application (2020-2025)
7.3 Global Small Molecule Drug CDMO Services Market Size (M USD) by Application (2020-2025)
7.4 Global Small Molecule Drug CDMO Services Sales Growth Rate by Application (2020-2025)
8 SMALL MOLECULE DRUG CDMO SERVICES MARKET SALES BY REGION
8.1 Global Small Molecule Drug CDMO Services Sales by Region
8.1.1 Global Small Molecule Drug CDMO Services Sales by Region
8.1.2 Global Small Molecule Drug CDMO Services Sales Market Share by Region
8.2 Global Small Molecule Drug CDMO Services Market Size by Region
8.2.1 Global Small Molecule Drug CDMO Services Market Size by Region
8.2.2 Global Small Molecule Drug CDMO Services Market Size Market Share by Region
8.3 North America
8.3.1 North America Small Molecule Drug CDMO Services Sales by Country
8.3.2 North America Small Molecule Drug CDMO Services Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Small Molecule Drug CDMO Services Sales by Country
8.4.2 Europe Small Molecule Drug CDMO Services Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Small Molecule Drug CDMO Services Sales by Region
8.5.2 Asia Pacific Small Molecule Drug CDMO Services Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Small Molecule Drug CDMO Services Sales by Country
8.6.2 South America Small Molecule Drug CDMO Services Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Small Molecule Drug CDMO Services Sales by Region
8.7.2 Middle East and Africa Small Molecule Drug CDMO Services Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 SMALL MOLECULE DRUG CDMO SERVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Small Molecule Drug CDMO Services by Region(2020-2025)
9.2 Global Small Molecule Drug CDMO Services Revenue Market Share by Region (2020-2025)
9.3 Global Small Molecule Drug CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Small Molecule Drug CDMO Services Production
9.4.1 North America Small Molecule Drug CDMO Services Production Growth Rate (2020-2025)
9.4.2 North America Small Molecule Drug CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Small Molecule Drug CDMO Services Production
9.5.1 Europe Small Molecule Drug CDMO Services Production Growth Rate (2020-2025)
9.5.2 Europe Small Molecule Drug CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Small Molecule Drug CDMO Services Production (2020-2025)
9.6.1 Japan Small Molecule Drug CDMO Services Production Growth Rate (2020-2025)
9.6.2 Japan Small Molecule Drug CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Small Molecule Drug CDMO Services Production (2020-2025)
9.7.1 China Small Molecule Drug CDMO Services Production Growth Rate (2020-2025)
9.7.2 China Small Molecule Drug CDMO Services Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Gliead
10.1.1 Gliead Basic Information
10.1.2 Gliead Small Molecule Drug CDMO Services Product Overview
10.1.3 Gliead Small Molecule Drug CDMO Services Product Market Performance
10.1.4 Gliead Business Overview
10.1.5 Gliead SWOT Analysis
10.1.6 Gliead Recent Developments
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Basic Information
10.2.2 Boehringer Ingelheim Small Molecule Drug CDMO Services Product Overview
10.2.3 Boehringer Ingelheim Small Molecule Drug CDMO Services Product Market Performance
10.2.4 Boehringer Ingelheim Business Overview
10.2.5 Boehringer Ingelheim SWOT Analysis
10.2.6 Boehringer Ingelheim Recent Developments
10.3 Vertex
10.3.1 Vertex Basic Information
10.3.2 Vertex Small Molecule Drug CDMO Services Product Overview
10.3.3 Vertex Small Molecule Drug CDMO Services Product Market Performance
10.3.4 Vertex Business Overview
10.3.5 Vertex SWOT Analysis
10.3.6 Vertex Recent Developments
10.4 Mirati Therapeutics
10.4.1 Mirati Therapeutics Basic Information
10.4.2 Mirati Therapeutics Small Molecule Drug CDMO Services Product Overview
10.4.3 Mirati Therapeutics Small Molecule Drug CDMO Services Product Market Performance
10.4.4 Mirati Therapeutics Business Overview
10.4.5 Mirati Therapeutics Recent Developments
10.5 AMPAC
10.5.1 AMPAC Basic Information
10.5.2 AMPAC Small Molecule Drug CDMO Services Product Overview
10.5.3 AMPAC Small Molecule Drug CDMO Services Product Market Performance
10.5.4 AMPAC Business Overview
10.5.5 AMPAC Recent Developments
10.6 Pfizer
10.6.1 Pfizer Basic Information
10.6.2 Pfizer Small Molecule Drug CDMO Services Product Overview
10.6.3 Pfizer Small Molecule Drug CDMO Services Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Polypeptide
10.7.1 Polypeptide Basic Information
10.7.2 Polypeptide Small Molecule Drug CDMO Services Product Overview
10.7.3 Polypeptide Small Molecule Drug CDMO Services Product Market Performance
10.7.4 Polypeptide Business Overview
10.7.5 Polypeptide Recent Developments
10.8 Bachem
10.8.1 Bachem Basic Information
10.8.2 Bachem Small Molecule Drug CDMO Services Product Overview
10.8.3 Bachem Small Molecule Drug CDMO Services Product Market Performance
10.8.4 Bachem Business Overview
10.8.5 Bachem Recent Developments
10.9 Merck
10.9.1 Merck Basic Information
10.9.2 Merck Small Molecule Drug CDMO Services Product Overview
10.9.3 Merck Small Molecule Drug CDMO Services Product Market Performance
10.9.4 Merck Business Overview
10.9.5 Merck Recent Developments
10.10 Asymchem
10.10.1 Asymchem Basic Information
10.10.2 Asymchem Small Molecule Drug CDMO Services Product Overview
10.10.3 Asymchem Small Molecule Drug CDMO Services Product Market Performance
10.10.4 Asymchem Business Overview
10.10.5 Asymchem Recent Developments
10.11 Thermo Fisher Scientific
10.11.1 Thermo Fisher Scientific Basic Information
10.11.2 Thermo Fisher Scientific Small Molecule Drug CDMO Services Product Overview
10.11.3 Thermo Fisher Scientific Small Molecule Drug CDMO Services Product Market Performance
10.11.4 Thermo Fisher Scientific Business Overview
10.11.5 Thermo Fisher Scientific Recent Developments
10.12 Zhejiang Jiuzhou Pharmaceutical
10.12.1 Zhejiang Jiuzhou Pharmaceutical Basic Information
10.12.2 Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Product Overview
10.12.3 Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Product Market Performance
10.12.4 Zhejiang Jiuzhou Pharmaceutical Business Overview
10.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
10.13 Porton Fine Chemicals
10.13.1 Porton Fine Chemicals Basic Information
10.13.2 Porton Fine Chemicals Small Molecule Drug CDMO Services Product Overview
10.13.3 Porton Fine Chemicals Small Molecule Drug CDMO Services Product Market Performance
10.13.4 Porton Fine Chemicals Business Overview
10.13.5 Porton Fine Chemicals Recent Developments
10.14 Lonza Group
10.14.1 Lonza Group Basic Information
10.14.2 Lonza Group Small Molecule Drug CDMO Services Product Overview
10.14.3 Lonza Group Small Molecule Drug CDMO Services Product Market Performance
10.14.4 Lonza Group Business Overview
10.14.5 Lonza Group Recent Developments
10.15 JOINN Biologics
10.15.1 JOINN Biologics Basic Information
10.15.2 JOINN Biologics Small Molecule Drug CDMO Services Product Overview
10.15.3 JOINN Biologics Small Molecule Drug CDMO Services Product Market Performance
10.15.4 JOINN Biologics Business Overview
10.15.5 JOINN Biologics Recent Developments
10.16 Zhejiang Langhua Pharmaceutical
10.16.1 Zhejiang Langhua Pharmaceutical Basic Information
10.16.2 Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Product Overview
10.16.3 Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Product Market Performance
10.16.4 Zhejiang Langhua Pharmaceutical Business Overview
10.16.5 Zhejiang Langhua Pharmaceutical Recent Developments
10.17 Kingchem (Liaoning) Life Science
10.17.1 Kingchem (Liaoning) Life Science Basic Information
10.17.2 Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Product Overview
10.17.3 Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Product Market Performance
10.17.4 Kingchem (Liaoning) Life Science Business Overview
10.17.5 Kingchem (Liaoning) Life Science Recent Developments
11 SMALL MOLECULE DRUG CDMO SERVICES MARKET FORECAST BY REGION
11.1 Global Small Molecule Drug CDMO Services Market Size Forecast
11.2 Global Small Molecule Drug CDMO Services Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Small Molecule Drug CDMO Services Market Size Forecast by Country
11.2.3 Asia Pacific Small Molecule Drug CDMO Services Market Size Forecast by Region
11.2.4 South America Small Molecule Drug CDMO Services Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Small Molecule Drug CDMO Services by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Small Molecule Drug CDMO Services Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Small Molecule Drug CDMO Services by Type (2026-2033)
12.1.2 Global Small Molecule Drug CDMO Services Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Small Molecule Drug CDMO Services by Type (2026-2033)
12.2 Global Small Molecule Drug CDMO Services Market Forecast by Application (2026-2033)
12.2.1 Global Small Molecule Drug CDMO Services Sales (K MT) Forecast by Application
12.2.2 Global Small Molecule Drug CDMO Services Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Small Molecule Drug CDMO Services Market Size Comparison by Region (M USD)
Table 5. Global Small Molecule Drug CDMO Services Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Small Molecule Drug CDMO Services Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Small Molecule Drug CDMO Services Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Small Molecule Drug CDMO Services Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO Services as of 2024)
Table 10. Global Market Small Molecule Drug CDMO Services Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Small Molecule Drug CDMO Services Manufacturing Sites and Area Served
Table 12. Manufacturers Small Molecule Drug CDMO Services Product Type
Table 13. Global Small Molecule Drug CDMO Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Small Molecule Drug CDMO Services Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Small Molecule Drug CDMO Services Sales by Type (K MT)
Table 25. Global Small Molecule Drug CDMO Services Market Size by Type (M USD)
Table 26. Global Small Molecule Drug CDMO Services Sales (K MT) by Type (2020-2025)
Table 27. Global Small Molecule Drug CDMO Services Sales Market Share by Type (2020-2025)
Table 28. Global Small Molecule Drug CDMO Services Market Size (M USD) by Type (2020-2025)
Table 29. Global Small Molecule Drug CDMO Services Market Size Share by Type (2020-2025)
Table 30. Global Small Molecule Drug CDMO Services Price (USD/MT) by Type (2020-2025)
Table 31. Global Small Molecule Drug CDMO Services Sales (K MT) by Application
Table 32. Global Small Molecule Drug CDMO Services Market Size by Application
Table 33. Global Small Molecule Drug CDMO Services Sales by Application (2020-2025) & (K MT)
Table 34. Global Small Molecule Drug CDMO Services Sales Market Share by Application (2020-2025)
Table 35. Global Small Molecule Drug CDMO Services Market Size by Application (2020-2025) & (M USD)
Table 36. Global Small Molecule Drug CDMO Services Market Share by Application (2020-2025)
Table 37. Global Small Molecule Drug CDMO Services Sales Growth Rate by Application (2020-2025)
Table 38. Global Small Molecule Drug CDMO Services Sales by Region (2020-2025) & (K MT)
Table 39. Global Small Molecule Drug CDMO Services Sales Market Share by Region (2020-2025)
Table 40. Global Small Molecule Drug CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 41. Global Small Molecule Drug CDMO Services Market Size Market Share by Region (2020-2025)
Table 42. North America Small Molecule Drug CDMO Services Sales by Country (2020-2025) & (K MT)
Table 43. North America Small Molecule Drug CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Small Molecule Drug CDMO Services Sales by Country (2020-2025) & (K MT)
Table 45. Europe Small Molecule Drug CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Small Molecule Drug CDMO Services Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Small Molecule Drug CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 48. South America Small Molecule Drug CDMO Services Sales by Country (2020-2025) & (K MT)
Table 49. South America Small Molecule Drug CDMO Services Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Small Molecule Drug CDMO Services Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Small Molecule Drug CDMO Services Market Size by Region (2020-2025) & (M USD)
Table 52. Global Small Molecule Drug CDMO Services Production (K MT) by Region(2020-2025)
Table 53. Global Small Molecule Drug CDMO Services Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Small Molecule Drug CDMO Services Revenue Market Share by Region (2020-2025)
Table 55. Global Small Molecule Drug CDMO Services Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Small Molecule Drug CDMO Services Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Small Molecule Drug CDMO Services Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Small Molecule Drug CDMO Services Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Small Molecule Drug CDMO Services Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Gliead Basic Information
Table 61. Gliead Small Molecule Drug CDMO Services Product Overview
Table 62. Gliead Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Gliead Business Overview
Table 64. Gliead SWOT Analysis
Table 65. Gliead Recent Developments
Table 66. Boehringer Ingelheim Basic Information
Table 67. Boehringer Ingelheim Small Molecule Drug CDMO Services Product Overview
Table 68. Boehringer Ingelheim Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim SWOT Analysis
Table 71. Boehringer Ingelheim Recent Developments
Table 72. Vertex Basic Information
Table 73. Vertex Small Molecule Drug CDMO Services Product Overview
Table 74. Vertex Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Vertex Business Overview
Table 76. Vertex SWOT Analysis
Table 77. Vertex Recent Developments
Table 78. Mirati Therapeutics Basic Information
Table 79. Mirati Therapeutics Small Molecule Drug CDMO Services Product Overview
Table 80. Mirati Therapeutics Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Mirati Therapeutics Business Overview
Table 82. Mirati Therapeutics Recent Developments
Table 83. AMPAC Basic Information
Table 84. AMPAC Small Molecule Drug CDMO Services Product Overview
Table 85. AMPAC Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. AMPAC Business Overview
Table 87. AMPAC Recent Developments
Table 88. Pfizer Basic Information
Table 89. Pfizer Small Molecule Drug CDMO Services Product Overview
Table 90. Pfizer Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Pfizer Business Overview
Table 92. Pfizer Recent Developments
Table 93. Polypeptide Basic Information
Table 94. Polypeptide Small Molecule Drug CDMO Services Product Overview
Table 95. Polypeptide Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Polypeptide Business Overview
Table 97. Polypeptide Recent Developments
Table 98. Bachem Basic Information
Table 99. Bachem Small Molecule Drug CDMO Services Product Overview
Table 100. Bachem Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Bachem Business Overview
Table 102. Bachem Recent Developments
Table 103. Merck Basic Information
Table 104. Merck Small Molecule Drug CDMO Services Product Overview
Table 105. Merck Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Merck Business Overview
Table 107. Merck Recent Developments
Table 108. Asymchem Basic Information
Table 109. Asymchem Small Molecule Drug CDMO Services Product Overview
Table 110. Asymchem Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Asymchem Business Overview
Table 112. Asymchem Recent Developments
Table 113. Thermo Fisher Scientific Basic Information
Table 114. Thermo Fisher Scientific Small Molecule Drug CDMO Services Product Overview
Table 115. Thermo Fisher Scientific Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Thermo Fisher Scientific Business Overview
Table 117. Thermo Fisher Scientific Recent Developments
Table 118. Zhejiang Jiuzhou Pharmaceutical Basic Information
Table 119. Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Product Overview
Table 120. Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 122. Zhejiang Jiuzhou Pharmaceutical Recent Developments
Table 123. Porton Fine Chemicals Basic Information
Table 124. Porton Fine Chemicals Small Molecule Drug CDMO Services Product Overview
Table 125. Porton Fine Chemicals Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 126. Porton Fine Chemicals Business Overview
Table 127. Porton Fine Chemicals Recent Developments
Table 128. Lonza Group Basic Information
Table 129. Lonza Group Small Molecule Drug CDMO Services Product Overview
Table 130. Lonza Group Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 131. Lonza Group Business Overview
Table 132. Lonza Group Recent Developments
Table 133. JOINN Biologics Basic Information
Table 134. JOINN Biologics Small Molecule Drug CDMO Services Product Overview
Table 135. JOINN Biologics Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 136. JOINN Biologics Business Overview
Table 137. JOINN Biologics Recent Developments
Table 138. Zhejiang Langhua Pharmaceutical Basic Information
Table 139. Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Product Overview
Table 140. Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 141. Zhejiang Langhua Pharmaceutical Business Overview
Table 142. Zhejiang Langhua Pharmaceutical Recent Developments
Table 143. Kingchem (Liaoning) Life Science Basic Information
Table 144. Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Product Overview
Table 145. Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 146. Kingchem (Liaoning) Life Science Business Overview
Table 147. Kingchem (Liaoning) Life Science Recent Developments
Table 148. Global Small Molecule Drug CDMO Services Sales Forecast by Region (2026-2033) & (K MT)
Table 149. Global Small Molecule Drug CDMO Services Market Size Forecast by Region (2026-2033) & (M USD)
Table 150. North America Small Molecule Drug CDMO Services Sales Forecast by Country (2026-2033) & (K MT)
Table 151. North America Small Molecule Drug CDMO Services Market Size Forecast by Country (2026-2033) & (M USD)
Table 152. Europe Small Molecule Drug CDMO Services Sales Forecast by Country (2026-2033) & (K MT)
Table 153. Europe Small Molecule Drug CDMO Services Market Size Forecast by Country (2026-2033) & (M USD)
Table 154. Asia Pacific Small Molecule Drug CDMO Services Sales Forecast by Region (2026-2033) & (K MT)
Table 155. Asia Pacific Small Molecule Drug CDMO Services Market Size Forecast by Region (2026-2033) & (M USD)
Table 156. South America Small Molecule Drug CDMO Services Sales Forecast by Country (2026-2033) & (K MT)
Table 157. South America Small Molecule Drug CDMO Services Market Size Forecast by Country (2026-2033) & (M USD)
Table 158. Middle East and Africa Small Molecule Drug CDMO Services Sales Forecast by Country (2026-2033) & (Units)
Table 159. Middle East and Africa Small Molecule Drug CDMO Services Market Size Forecast by Country (2026-2033) & (M USD)
Table 160. Global Small Molecule Drug CDMO Services Sales Forecast by Type (2026-2033) & (K MT)
Table 161. Global Small Molecule Drug CDMO Services Market Size Forecast by Type (2026-2033) & (M USD)
Table 162. Global Small Molecule Drug CDMO Services Price Forecast by Type (2026-2033) & (USD/MT)
Table 163. Global Small Molecule Drug CDMO Services Sales (K MT) Forecast by Application (2026-2033)
Table 164. Global Small Molecule Drug CDMO Services Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Small Molecule Drug CDMO Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Small Molecule Drug CDMO Services Market Size (M USD), 2024-2033
Figure 5. Global Small Molecule Drug CDMO Services Market Size (M USD) (2020-2033)
Figure 6. Global Small Molecule Drug CDMO Services Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Small Molecule Drug CDMO Services Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Small Molecule Drug CDMO Services Product Life Cycle
Figure 13. Small Molecule Drug CDMO Services Sales Share by Manufacturers in 2024
Figure 14. Global Small Molecule Drug CDMO Services Revenue Share by Manufacturers in 2024
Figure 15. Small Molecule Drug CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Small Molecule Drug CDMO Services Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Small Molecule Drug CDMO Services Revenue in 2024
Figure 18. Industry Chain Map of Small Molecule Drug CDMO Services
Figure 19. Global Small Molecule Drug CDMO Services Market PEST Analysis
Figure 20. Global Small Molecule Drug CDMO Services Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Small Molecule Drug CDMO Services Market Share by Type
Figure 27. Sales Market Share of Small Molecule Drug CDMO Services by Type (2020-2025)
Figure 28. Sales Market Share of Small Molecule Drug CDMO Services by Type in 2024
Figure 29. Market Size Share of Small Molecule Drug CDMO Services by Type (2020-2025)
Figure 30. Market Size Share of Small Molecule Drug CDMO Services by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Small Molecule Drug CDMO Services Market Share by Application
Figure 33. Global Small Molecule Drug CDMO Services Sales Market Share by Application (2020-2025)
Figure 34. Global Small Molecule Drug CDMO Services Sales Market Share by Application in 2024
Figure 35. Global Small Molecule Drug CDMO Services Market Share by Application (2020-2025)
Figure 36. Global Small Molecule Drug CDMO Services Market Share by Application in 2024
Figure 37. Global Small Molecule Drug CDMO Services Sales Growth Rate by Application (2020-2025)
Figure 38. Global Small Molecule Drug CDMO Services Sales Market Share by Region (2020-2025)
Figure 39. Global Small Molecule Drug CDMO Services Market Size Market Share by Region (2020-2025)
Figure 40. North America Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Small Molecule Drug CDMO Services Sales Market Share by Country in 2024
Figure 43. North America Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Small Molecule Drug CDMO Services Market Size Market Share by Country in 2024
Figure 45. U.S. Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Small Molecule Drug CDMO Services Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Small Molecule Drug CDMO Services Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Small Molecule Drug CDMO Services Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Small Molecule Drug CDMO Services Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Small Molecule Drug CDMO Services Sales Market Share by Country in 2024
Figure 53. Europe Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Small Molecule Drug CDMO Services Market Size Market Share by Country in 2024
Figure 55. Germany Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Small Molecule Drug CDMO Services Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Small Molecule Drug CDMO Services Sales Market Share by Region in 2024
Figure 67. Asia Pacific Small Molecule Drug CDMO Services Market Size Market Share by Region in 2024
Figure 68. China Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Small Molecule Drug CDMO Services Sales and Growth Rate (K MT)
Figure 79. South America Small Molecule Drug CDMO Services Sales Market Share by Country in 2024
Figure 80. South America Small Molecule Drug CDMO Services Market Size and Growth Rate (M USD)
Figure 81. South America Small Molecule Drug CDMO Services Market Size Market Share by Country in 2024
Figure 82. Brazil Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Small Molecule Drug CDMO Services Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Small Molecule Drug CDMO Services Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Small Molecule Drug CDMO Services Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Small Molecule Drug CDMO Services Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Small Molecule Drug CDMO Services Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Small Molecule Drug CDMO Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Small Molecule Drug CDMO Services Production Market Share by Region (2020-2025)
Figure 103. North America Small Molecule Drug CDMO Services Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Small Molecule Drug CDMO Services Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Small Molecule Drug CDMO Services Production (K MT) Growth Rate (2020-2025)
Figure 106. China Small Molecule Drug CDMO Services Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Small Molecule Drug CDMO Services Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Small Molecule Drug CDMO Services Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Small Molecule Drug CDMO Services Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Small Molecule Drug CDMO Services Market Share Forecast by Type (2026-2033)
Figure 111. Global Small Molecule Drug CDMO Services Sales Forecast by Application (2026-2033)
Figure 112. Global Small Molecule Drug CDMO Services Market Share Forecast by Application (2026-2033)
